Neueste Versuche

EudraCT Number: 2004-004415-29 Sponsor Protocol Number: DU176b-PRT007 Start Date: 2005-04-18
Sponsor Name: Daiichi Medical Research Inc
Full Title: A Phase IIa, multi-center, multi-national, open-label, dose ranging study of the efficacy, safety, and tolerability of oral DU-176b administered once or twice daily in the treatment of adult patien...
Medical condition: Prophylaxis of venous thromboembolism
Disease: Version SOC Term Classification Code Term Level
7.1 10049909 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) LV (Completed)
Trial results: View results
EudraCT Number: 2004-005051-34 Sponsor Protocol Number: 42-73-305 / WIL1-0305 Start Date: 2005-04-18
Sponsor Name: LFB BIOTECHNOLOGIES
Full Title: Efficacy and safety study of vWF SD-35-DH (WILFACTIN) in children under 6 years of age
Medical condition: Von Willebrand disease
Disease: Version SOC Term Classification Code Term Level
10047715
Population Age: Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: View results
EudraCT Number: 2004-005078-22 Sponsor Protocol Number: QUETIAPINKOGNSCHIZOPHR Start Date: 2005-04-18
Sponsor Name: Medical School of Hannover
Full Title: Quetiapin: Zur Sicherheit, Verträglichkeit und zum Einfluss auf kognitive Funktionen bei Patienten/innen mit einer schizophrenen Psychose Quetiapine: safety and influence on cognitive functions i...
Medical condition: Patients with schizophrenia, who are not in an acute state of psychosis at enrolment (PANSS score
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2005-001380-61 Sponsor Protocol Number: CSTI5710102E2 Start Date: 2005-04-15
Sponsor Name: NOVARTIS FARMA
Full Title: An extension to a phase II open label study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome positive chronic myeloid leukemia in myeloid blast c...
Medical condition: Ph+ CML in myeloid blast crisis
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009013 Chronic myeloid leukaemia PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2005-001382-33 Sponsor Protocol Number: CSTI5710110E2 Start Date: 2005-04-15
Sponsor Name: NOVARTIS FARMA
Full Title: An extension to a phase II study to determine the efficacy and the safety of STI571 in patients with chronic myeloid leukemia who are refractory to or intolerant of interferon-alpha
Medical condition: treatment of patients with CML who are refractory to or intolerant of interferon alpha.
Disease: Version SOC Term Classification Code Term Level
14.1 100000004864 10052065 Chronic phase chronic myeloid leukaemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-004158-23 Sponsor Protocol Number: 3303 Start Date: 2005-04-15
Sponsor Name: IST. DI RICERCHE FARMACOLOG. M. NEGRI
Full Title: DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL ON THE USE OF ACETYL-L-CARNITINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
Medical condition: Amyotrophic lateral sclerosis therapy
Disease: Version SOC Term Classification Code Term Level
9.1 10002026 Amyotrophic lateral sclerosis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-004528-11 Sponsor Protocol Number: BM18102 Start Date: 2005-04-15
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: Multicenter, double-blind, randomized, placebo-controlled, dose ranging phase 2 study to investigate efficacy, safety, tolerability and pharmacokinetics of the DPPIV inhibitor RO0730699 in patients...
Medical condition: Type 2 diabetes
Disease: Version SOC Term Classification Code Term Level
7 10012613 low
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) EE (Completed) LV (Completed)
Trial results: View results
EudraCT Number: 2004-005123-18 Sponsor Protocol Number: 104020 Start Date: 2005-04-15
Sponsor Name: GlaxoSmithKline
Full Title: A phase III, partially blind, randomised, primary vaccination study to assess the immunogenicity and safety of three different lots of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mum...
Medical condition: Active immunization of healthy children during their second year of life against measles, mumps, rubella and varicella diseases.
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: FI (Completed) DE (Completed)
Trial results: View results
EudraCT Number: 2004-004876-36 Sponsor Protocol Number: 05/Q0108/5 Start Date: 2005-04-15
Sponsor Name: Addenbrookes Hospital NHS Trust
Full Title: AN INVESTIGATION INTO THE ROLE OF MATRIX METALLOPROTEINASES (MMP’s) IN LOWER LIMB VASCULAR RESTENOSIS
Medical condition: Post angioplasty and post vein graft stenosis.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2005-000427-42 Sponsor Protocol Number: LT 2005 XX Start Date: 2005-04-15
Sponsor Name: UK Children’s Cancer Study Group
Full Title: SIOPEL 5 (HCC-1) trial on the hepatocellular carcinoma family of tumours in children/adolescents and young adults
Medical condition: Hepatocellular carcinoma
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren